Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genetic Lingo01:11

Genetic Lingo

Overview
Multiple Allele Traits01:49

Multiple Allele Traits

The Concept of Multiple Allelism
Blood Types02:20

Blood Types

Human blood is classified into different types based on the presence of antigens on the red blood cell's surface and antibodies in the plasma. Proper identification of blood type is essential for successful blood transfusion. The International Society of Blood Transfusion has identified 38 human blood types based on the surface antigens on the red blood cells. The most common types are ABO, Rh, and MNS blood types.
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CD226 (DNAM-1) is associated with susceptibility to juvenile idiopathic arthritis.

Annals of the rheumatic diseases·2014
Same author

Genetic variation in VTCN1 (B7-H4) is associated with course of disease in juvenile idiopathic arthritis.

Annals of the rheumatic diseases·2013
Same author

Genetic variants in the region of the C1q genes are associated with rheumatoid arthritis.

Clinical and experimental immunology·2013
Same author

Annual rate of progression of aortic-jet velocity and survival in cases of severe asymptomatic aortic stenosis.

Prilozi·2009
Same author

Association of the autoimmunity locus 4q27 with juvenile idiopathic arthritis.

Arthritis and rheumatism·2009
Same author

The TRAF1/C5 region is a risk factor for polyarthritis in juvenile idiopathic arthritis.

Annals of the rheumatic diseases·2008
Same journal

Corrigendum.

Tissue antigens·2015
Same journal

Nomenclature for factors of the HLA system, update September 2015.

Tissue antigens·2015
Same journal

Nomenclature for factors of the HLA system, update August 2015.

Tissue antigens·2015
Same journal

Nomenclature for factors of the HLA system, update July 2015.

Tissue antigens·2015
Same journal

Four amino acid exchanges located in the alpha-2 domain specify the novel HLA-B*50:20 allele.

Tissue antigens·2015
Same journal

A novel HLA-A*02 variant, HLA-A*02:575, detected in a Taiwanese bone marrow hematopoietic stem cell donor.

Tissue antigens·2015
See all related articles

Related Experiment Video

Updated: Jun 19, 2026

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

HLA-DRB and -DQB1 polymorphism in the Macedonian population.

A Hristova-Dimceva1, W Verduijn, R F Schipper

  • 1Institute of Blood Transfusion, Skopje, Republic of Macedonia.

Tissue Antigens
|March 7, 2000
PubMed
Summary
This summary is machine-generated.

This study details human leukocyte antigen (HLA) gene polymorphism in Macedonians. Researchers identified frequent HLA-DRB1 and DQB1 alleles and common three-locus haplotypes, noting some unusual DR2-related findings in this population.

More Related Videos

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
08:07

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis
09:32

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis

Published on: October 15, 2021

Related Experiment Videos

Last Updated: Jun 19, 2026

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
08:07

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis
09:32

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis

Published on: October 15, 2021

Area of Science:

  • Immunogenetics
  • Population Genetics
  • Molecular Anthropology

Background:

  • Human Leukocyte Antigen (HLA) genes are crucial for immune response and transplantation.
  • Understanding HLA polymorphism in diverse populations is essential for medical and anthropological insights.
  • Previous HLA studies in Macedonian populations are limited, necessitating detailed genetic characterization.

Purpose of the Study:

  • To investigate the polymorphism of HLA-DRB1, DRB3/4/5, and DQB1 loci in a healthy Macedonian population.
  • To identify common alleles and haplotypes within this specific ethnic group.
  • To compare findings with other European populations and identify any unique genetic patterns.

Main Methods:

  • Molecular methods were employed to analyze DNA from 80 unrelated healthy Macedonian individuals.
  • High-resolution typing was performed for HLA-DRB1, DRB3/4/5, and DQB1 gene regions.
  • Statistical analysis was used to determine allele and haplotype frequencies.

Main Results:

  • Twenty-five distinct DRB1 alleles were identified, with DRB1*1104, *1501, *1601, and *1101 being the most prevalent.
  • Fifteen DQB1 alleles were found, dominated by DQB1*0301 and *0502.
  • The most frequent three-locus haplotypes were DRB1*1104-DRB3*02-DQB1*0301 (18%), DRB1*1101-DRB3*02-DQB1*0301 (9%), and DRB1*1601-DRB5*02-DQB1*0502 (10%).
  • Extensive polymorphism was observed for DRB1*04, *13, and *15 haplotypes, including eleven DR2-related haplotypes, some uncommon in Europeans.

Conclusions:

  • The study provides a comprehensive profile of HLA-DRB1, DRB3/4/5, and DQB1 genetic variation in Macedonians.
  • Identified allele and haplotype frequencies contribute valuable data for anthropological and clinical applications in the region.
  • The presence of unusual DR2-related haplotypes suggests unique evolutionary or historical influences on the Macedonian gene pool.